Results:

MMRF Research Roundtables encourage the sharing of ideas and knowledge, and build a team approach to finding a cure in cutting-edge areas of research. MMRF Roundtables bring together world leaders in academic research, the NCI, and the pharmaceutical industry. MMRF Roundtables are closed door, invitation only (limited to 25 participants), interactive sessions whereby everyone in attendance presents their unpublished work. Meeting abstract books are disseminated to participants and a meeting summary may be submitted to peer-reviewed journals.

Research Roundtables

2011

• March 16-17 – Boston, MA
  Advancing the Field of Epigenetics in Multiple Myeloma to Identify New Targets and Therapeutics
  
  
• March 8 - 9 – San Francisco, CA
  Personalized Medicine Strategic Investment Board
  
  
• March 3 – Boston, MA
  MMRF Longitudinal Study Scientific Advisory Board Meeting
  
  
• February 10 – Boston MA
  Partnering to Advance Personalized Medicine in Multiple Myeloma
  
  

2010

• May 26 - Boston, MA
  Partnering to Advance Personalized Medicine in Multiple Myeloma
  
  
• March 23-24 - Falls Church, VA
  Opportunities and Challenges in Myeloma Drug Development in the Era of Personalized Medicine
  
  

2009

• June 23-24 – Greenwich, CT
  Accelerating Drug Development: Results and Progress Toward a Cure
  
  
• June 23 – Norwalk, CT
  Tissue Bank Roundtable: Current Use and Future Direction
  
  
• February 17, 2009
  2009 Scientific Agenda Roundtable
  
  
• January 27-28 – New York, NY
  Cancer Stem Cell Research Strategies: Applications to Multiple Myeloma
  
  

2008

• July 23-24 – Washington, DC
  Opportunities and Challenges in the Myeloma Drug Development Process
  
  
• June 13 – New Orleans, LA
  Clinical Imaging in the Diagnosis and Treatment of Multiple Myeloma
  
  

2007

• January 29-30 - Tampa, FL
  Combination Strategies in the Treatment of Multiple Myeloma Research Roundtable
  
  

2005

• November 21-22 - New York, NY
  Validating Compounds for Multiple Myeloma
  
  
• June 15-16 - Washington, DC
  A Strategic Framework for Novel Drug Development in Multiple Myeloma
  
  
• February 1 - New York, NY
  Therapeutic Targets Research Roundtable